Narayana Pineda-Ramírez

Dr. Narayana Pineda-Ramírez

Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez"

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2019 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
NPNarayana Pineda-Ramírez
Narayana Pineda-Ramírez
IAIVAN ALQUISIRAS
IVAN ALQUISIRAS
AOAlma Ortiz-Plata
Alma Ortiz-Plata
MRMartha-Eugenia Ruiz-Tachiquín
Martha-Eugenia Ruiz-Tachiquín
MEMónica Espinoza-Rojo
Mónica Espinoza-Rojo
PAPenelope Aguilera
Penelope Aguilera

14 February 2017 in Nutritional Neuroscience
Verified
Journal Article
Closed access
NPNarayana Pineda-Ramírez
Narayana Pineda-Ramírez
GAGermán Fernando Gutiérrez Aguilar
Germán Fernando Gutiérrez Aguilar
MEMónica Espinoza-Rojo
Mónica Espinoza-Rojo
PAPenelope Aguilera
Penelope Aguilera
Objectives: Cerebral ischemia is a neurological condition in which energetics and oxidative stress are dysregulated. Resveratrol is a stilbene with potent pharmacological effects associated with its antioxidant properties. In the brain, resveratrol produces protective responses against ischemia, decreases infarct volume and improves neurological function. Adenosine monophosphate-activated protein kinase (AMPK) is a cellular sensor that acts as a switch to initiate adaptive changes in response to fluctuations in energy metabolism. Results: In ischemia, AMPK is activated, nevertheless conflicting results about its contribution to protection have become apparent, and this matter continues without resolution. Interestingly, AMPK activation by resveratrol has been implicated in regulating cell survival in different experimental models. Although resveratrol's ability to regulate AMPK directly or after signaling is only beginning to be understood, targeting this enzyme by resveratrol in brain suggest that it could contribute to the amelioration of some pathologic features induced after an energetic deficit. Conclusion: The present review discusses the potential role of resveratrol in regulating AMPK activity on brain before, during, or after ischemia and offer suggestions for feasible future studies.

20 March 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
NPNarayana Pineda-Ramírez
Narayana Pineda-Ramírez
Fernando CalzadaFernando Calzada
Fernando Calzada
IAIVAN ALQUISIRAS
IVAN ALQUISIRAS
OMOmar Noel Medina-Campos
Omar Noel Medina-Campos
José Pedraza-ChaverriJosé Pedraza-Chaverri
José Pedraza-Chaverri
PAPenelope Aguilera
Penelope Aguilera
This study aimed to compare the antioxidant activities of extracts obtained from three plant families and evaluate their therapeutic effect on strokes. Ethanol extracts were obtained from either the leaf or the aerial parts of plants of the families Annonaceae (Annona cherimola, A. diversifolia, A. muricata, A. purpurea, and A. reticulata), Lamiaceae (Salvia amaríssima and S. polystachya), and Geraniaceae (Geranium niveum and G. mexicanum). Extracts were analyzed in terms of hydroxyl radical (OH•), peroxyl radical (ROO•), and superoxide anion (O2•−). The efficiency of the extracts to prevent neuronal death induced by excitotoxicity was tested with the tetrazolium assay, the O2•− scavenging capacity was evaluated with the dihydroethidium dye, and the protective effect of the extracts with the highest antioxidant activity was tested on a stroke experimental model. The extracts’ IC50 values (μg/mL) of scavenging varied from 98.9 to 155.04, 4.5 to 102.4, and 20.2 to 118.97 for OH•, ROO•, and O2•−, respectively. In the excitotoxicity model, Annonaceae extracts were highly cytotoxic while Lamiaceae and Geraniaceae reduced intracellular O2•− production and protect neurons against oxidative stress. Salvia polystachya reduced cerebral damage, as well as improved survival and behavior after ischemia. Our results encouraged the use of plant extracts as natural antioxidants to minimize neuronal injury following stroke.

20 September 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
GAGermán Fernando Gutiérrez Aguilar
Germán Fernando Gutiérrez Aguilar
IAIVAN ALQUISIRAS
IVAN ALQUISIRAS
JFJavier Franco-Pérez
Javier Franco-Pérez
NPNarayana Pineda-Ramírez
Narayana Pineda-Ramírez
AOAlma Ortiz-Plata
Alma Ortiz-Plata
PAPenelope Aguilera
Penelope Aguilera
Glucose transporter (GLUT)3 up-regulation is an adaptive response activated to prevent cellular damage when brain metabolic energy is reduced. Resveratrol is a natural polyphenol with anti-oxidant and anti-inflammatory features that protects neurons against damage induced in cerebral ischemia. Since transcription factors sensitive to oxidative stress and inflammation modulate GLUT3 expression, the purpose of this work was to assess the effect of resveratrol on GLUT3 expression levels after ischemia. Male Wistar rats were subjected to 2 h of middle cerebral artery occlusion (MCAO) followed by different times of reperfusion. Resveratrol (1.9 mg/kg; i. p.) was administered at the onset of the restoration of the blood flow. Quantitative-PCR and Western blot showed that MCAO provoked a substantial increase in GLUT3 expression in the ipsilateral side to the lesion of the cerebral cortex. Immunofluorescence assays indicated that GLUT3 levels were upregulated in astrocytes. Additionally, an important increase in GLUT3 occurred in other cellular types (e.g., damaged neurons, microglia, or infiltrated macrophages). Immunodetection of the microtubule-associated protein 2 (MAP2) showed that MCAO induced severe damage to the neuronal population. However, the administration of resveratrol at the time of reperfusion resulted in injury reduction. Resveratrol also prevented the MCAO-induced increase of GLUT3 expression. In conclusion, resveratrol protects neurons from damage induced by ischemia and prevents GLUT3 upregulation in the damaged brain that might depend on AMPK activation.

2 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
OPOlatz Pampliega
Olatz Pampliega
FSFederico Soria
Federico Soria
NPNarayana Pineda-Ramírez
Narayana Pineda-Ramírez
Erwan BezardErwan Bezard
Erwan Bezard
The major neurodegenerative diseases, like Alzheimer’s disease (AD), accumulate neuropathogenic proteins that compromise autophagic function. In AD, autophagy contributes to intracellular APP processing and amyloid beta (Aβ) generation by mutant presenilin-1 (PS1). However, how extracellular soluble Aβ oligomers (Aβo) impact intracellular autophagy is not well understood. The primary cilium (PC), a signaling organelle on the surface of mature neurons and glia, is able to bind Aβ. Since PC signaling pathways knowingly modify autophagy in non-brain cells, we here investigated the role of neuronal PC in the modulation of autophagy during acute extracellular Aβo overload. Our results show that, in vivo , recombinant Aβo require the presence of neuronal PC to modulate early autophagy and to induce the accumulation of autophagic vacuoles in an age-dependent manner. We show that activated Akt mediates these effects in an age-dependent manner, and that ciliary p75NTR receptor is required to block autophagy by Aβo. These findings demonstrate that neuronal PC in the adult brain participates in the deleterious effects mediated by soluble Aβo. The PC should therefore be considered as a target organelle to modulate autophagy for the treatment of neurodegenerative diseases. Highlights: Aβo requires the neuronal PC to impair learning in young and old mice. Autophagy in whole hippocampus differs from autophagy response in hippocampal neurons. Aβo induce autophagolysosome accumulation through primary cilia- and age-dependent Akt phosphorylation.